Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis

Background Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistoch...

Full description

Bibliographic Details
Main Authors: Jung-Soo Pyo, Nae Yu Kim, Won Jin Cho
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2019-05-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdf
_version_ 1818153933592330240
author Jung-Soo Pyo
Nae Yu Kim
Won Jin Cho
author_facet Jung-Soo Pyo
Nae Yu Kim
Won Jin Cho
author_sort Jung-Soo Pyo
collection DOAJ
description Background Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.
first_indexed 2024-12-11T14:18:29Z
format Article
id doaj.art-a726bf6edf614c1898ccc90dd81c72b9
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-12-11T14:18:29Z
publishDate 2019-05-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-a726bf6edf614c1898ccc90dd81c72b92022-12-22T01:03:03ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452019-05-0153317317910.4132/jptm.2019.02.0316823Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-AnalysisJung-Soo PyoNae Yu Kim0Won Jin Cho1 Departments of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea Department of Urology, Chosun University Hospital, Chosun University School of Medicine, Gwangju, KoreaBackground Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdfClaudin-1ImmunohistochemistryPrognosisMalignancyMeta-analysis
spellingShingle Jung-Soo Pyo
Nae Yu Kim
Won Jin Cho
Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
Journal of Pathology and Translational Medicine
Claudin-1
Immunohistochemistry
Prognosis
Malignancy
Meta-analysis
title Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
title_full Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
title_fullStr Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
title_full_unstemmed Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
title_short Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
title_sort prognostic role of claudin 1 immunohistochemistry in malignant solid tumors a meta analysis
topic Claudin-1
Immunohistochemistry
Prognosis
Malignancy
Meta-analysis
url http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdf
work_keys_str_mv AT jungsoopyo prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis
AT naeyukim prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis
AT wonjincho prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis